UK 21:22 Monday, 21 September 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Heaven knows why this US based POS maintains a dual listing on the (sub) Standard List. It really is a cash guzzling crock as we have pointed out on numerous occasions HERE. In the first part of this year Okyo Pharma (OKYO) managed to pump its shares up to 5.5p with a series of spurious and ramptastic RNS’s. Then as the Bulletin Board Morons took they trousers down, whoosh, a $5.5 million funding arranged by the company not its brokers, came in at just 1.85p. Ouch. And double ouch. One hopes that the morons had lubed up.
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
